The major business of the Canget BioTekpharma Company is to discover, and bring to market, highly effective low toxicity anti-cancer drugs.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free